Latest Content

Zegfrovy helped patients live longer without cancer growth and improved tumor response compared with chemotherapy in first-line lung cancer treatment.

A living liver donor shares recovery, fatigue and the lasting reward of helping his father heal after transplant surgery.

An overview of stage 1 lymphocyte-rich Hodgkin lymphoma covers diagnosis, treatment options and side effects to help guide patient care decisions.

Dr. Hope Rugo and advocate Jonise Louis discuss new ADCs, biomarker testing, and patient-centered dosing for metastatic triple-negative breast cancer.

High-risk essential thrombocythemia is manageable with treatment focused on preventing blood clots and maintaining safe platelet levels.

After a liver cancer diagnosis, one son stepped forward as a living donor, turning uncertainty into hope through a life-saving decision.

Functional precision medicine uses a patient’s tumor cells to test drugs, helping guide more personalized brain tumor treatment decisions.

Study shows home-based IV chemotherapy at Mayo Clinic was safely delivered with close monitoring, reducing treatment burden for patients with cancer.

Metastatic breast cancer survivor Casey Liening shares her adoption story in a candid interview.

A couple shares how open communication reshaped their relationship during and after liver cancer treatment.

We often face difficult decisions with patients and family members. Are the side effects of treatment worth the benefits? Is cure achievable, and at what cost?

For Kathy Small Wrice, a 20-year journey with multiple myeloma began not with a clear answer, but with a persistent intuition.

Patients with cancer are referred for psychosocial support to address emotional distress and mental health needs, according to a new study.